Stryker (SYK) Intrinsic Value Calculator

Updated: Nov 16, 2026

Stryker (SYK) trades at $310.90 against a base-case intrinsic value of $283.53 — roughly a 10% premium to fair value. The model starts from $16.29 in expected earnings per share, grows it at 9.8% annually (analyst consensus) decaying to a 4% terminal rate by Year 5, applies a 20.1x exit multiple, and discounts the result back at 10% per year. At today's price, the market is pricing in either faster earnings growth or a higher exit multiple than SYK's own history supports. Use the sliders below to see what growth assumptions would be needed to justify the current price.

Overvalued by 8.8%
Current Price
$310.90
Intrinsic Value
$283.53
Implied Upside: -8.8%

Discounted Cash Flow with Growth Decay Model

Customize Your Valuation

Adjust the assumptions below to model different scenarios. The intrinsic value updates in real-time.

Conservative
Base Case
Aggressive
Time Horizon 5 years
3 years 10 years
Initial Growth Rate 9.8%
0% (No Growth) 50% (High Growth)
Terminal Growth Rate 4.0%
0% (Decline) 6% (GDP+)
Discount Rate (Required Return) 10.0%
5% (Low Risk) 15% (High Risk)
Exit PE Multiple 20.1x
8x (Value) 40x (Growth)
Calculated Intrinsic Value
$283.53
--
Tradestie Long-Horizon Cycle Intelligence (2007–2025 • Split-Invariant)

Tradestie Long-Horizon Financial Resilience & Peer Growth Benchmark (19-Year Cycle Analysis)

Outside-View Peer Growth Benchmark Surgical & Medical Instruments & Apparatus • 2498+ US Equities Benchmarked

Across 19 years of multi-cycle financial history in Surgical & Medical Instruments & Apparatus, only 28.7% of peer companies at >$10B revenue scale (101 historical 5-year windows; industry median CAGR: 3.8%/yr) sustained ≥8%/yr 5-year compound revenue growth (broad >$10B equity base rate: 22.9%).

≥5%/yr (5Y)
41.6%
All >$10B: 39.7%
≥10%/yr (5Y)
14.9%
All >$10B: 15.2%
≥15%/yr (5Y)
2.0%
All >$10B: 6.3%
≥20%/yr (5Y)
0.0%
All >$10B: 3.0%
≥25%/yr (5Y)
0.0%
All >$10B: 1.8%
≥30%/yr (5Y)
0.0%
All >$10B: 1.2%
19-Yr Revenue Scale
$6.00B → $25.12B
18Y CAGR: +8.3%/yr • 5Y: +11.8%
2008–2009 Cycle Trough Floor
22.6% Op Margin
FY2008 Rev: $6.72B (+12.0% YoY)
2022 Rate-Shock Floor
15.4% Op Margin
FY2022 Rev: $18.45B (+7.8% YoY)
Latest vs Cycle Median Margin
19.5% vs 18.7% med
100% Operating Profitable Across Tracked Cycles
Multi-Cycle Revenue & Operating Margin Trajectory (2007–2025) Expansion 2008–09 / 2022 Macro Stress
22%
'07
23%
'08
24%
'09
24%
'10
20%
'11
20%
'12
14%
'13
13%
'14
19%
'15
19%
'16
19%
'17
19%
'18
18%
'19
16%
'20
15%
'21
15%
'22
19%
'23
16%
'24
20%
'25
Inspect All 19 Fiscal Years of Annual Revenue & Operating Margin History Toggle Annual Ledger ↓
Fiscal Year Annual Revenue YoY Growth Operating Income Operating Margin Macro Cycle Regime
FY2025 (2025-12) $25.12B +11.2% $4.89B 19.5% Standard
FY2024 (2024-12) $22.59B +10.2% $3.69B 16.3% Standard
FY2023 (2023-12) $20.50B +11.1% $3.89B 19.0% Standard
FY2022 (2022-12) $18.45B +7.8% $2.84B 15.4% 2022 Rate Shock
FY2021 (2021-12) $17.11B +19.2% $2.58B 15.1% Standard
FY2020 (2020-12) $14.35B -3.6% $2.22B 15.5% Standard
FY2019 (2019-12) $14.88B +9.4% $2.71B 18.2% Standard
FY2018 (2018-12) $13.60B +9.3% $2.54B 18.7% Standard
FY2017 (2017-12) $12.44B +9.9% $2.30B 18.5% Standard
FY2016 (2016-12) $11.32B +13.9% $2.17B 19.2% Standard
FY2015 (2015-12) $9.95B +2.8% $1.86B 18.7% Standard
FY2014 (2014-12) $9.68B +7.2% $1.25B 12.9% Standard
FY2013 (2013-12) $9.02B +4.2% $1.26B 13.9% Standard
FY2012 (2012-12) $8.66B +4.2% $1.74B 20.1% Standard
FY2011 (2011-12) $8.31B +13.5% $1.69B 20.3% Standard
FY2010 (2010-12) $7.32B +8.9% $1.75B 23.9% Standard
FY2009 (2009-12) $6.72B +0.1% $1.59B 23.7% 2008–09 Cycle Stress
FY2008 (2008-12) $6.72B +12.0% $1.52B 22.6% 2008–09 Trough Floor
FY2007 (2007-12) $6.00B — $1.31B 21.8% Standard

Year-by-Year Projections

EPS growth decays from initial rate to terminal rate over the projection period.

Year Growth Rate EPS Stock Price Present Value

Price Projection

Sensitivity Analysis

How intrinsic value changes with different growth and discount rate assumptions.

Model Inputs
Base EPS $16.29
Current Price $310.90
Historical PE 20.1x
Analyst Growth Est. 9.8%
How It Works

Growth Decay Model: We project EPS growth that gradually slows from the initial rate to a terminal rate (typically 3-4%, matching long-term GDP growth).

Terminal Value: At the end of the projection period, we apply an exit PE multiple to estimate the future stock price.

Discounting: Future values are discounted back to today using your required rate of return (discount rate).